# Remifentanil Infusion Alone During the Closure Period for Early Emergence Following Craniotomy

> **NCT02593942** · PHASE4 · COMPLETED · sponsor: **Yeditepe University Hospital** · enrollment: 80 (actual)

## Conditions studied

- Supratentorial Neoplasms

## Interventions

- **DRUG:** Remifentanil
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT02593942
- **Lead sponsor:** Yeditepe University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2015-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02593942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02593942, "Remifentanil Infusion Alone During the Closure Period for Early Emergence Following Craniotomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02593942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*